211 related articles for article (PubMed ID: 17003308)
1. Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes.
Bhatia V; Chaudhuri A; Tomar R; Dhindsa S; Ghanim H; Dandona P
Diabetes Care; 2006 Oct; 29(10):2289-94. PubMed ID: 17003308
[TBL] [Abstract][Full Text] [Related]
2. Hypogonadotropic hypogonadism in men with type 2 diabetes.
Dandona P; Dhindsa S; Chandel A; Chaudhuri A
Postgrad Med; 2009 May; 121(3):45-51. PubMed ID: 19491539
[TBL] [Abstract][Full Text] [Related]
3. Hypogonadotrophic hypogonadism in type 2 diabetes.
Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S
Aging Male; 2008 Sep; 11(3):107-17. PubMed ID: 18821286
[TBL] [Abstract][Full Text] [Related]
4. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
5. Low testosterone and anaemia in men with type 2 diabetes.
Grossmann M; Panagiotopolous S; Sharpe K; MacIsaac RJ; Clarke S; Zajac JD; Jerums G; Thomas MC
Clin Endocrinol (Oxf); 2009 Apr; 70(4):547-53. PubMed ID: 18702678
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.
Kapoor D; Aldred H; Clark S; Channer KS; Jones TH
Diabetes Care; 2007 Apr; 30(4):911-7. PubMed ID: 17392552
[TBL] [Abstract][Full Text] [Related]
7. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
Dougherty RH; Rohrer JL; Hayden D; Rubin SD; Leder BZ
Clin Endocrinol (Oxf); 2005 Feb; 62(2):228-35. PubMed ID: 15670201
[TBL] [Abstract][Full Text] [Related]
8. Relationship between low serum endogenous androgen concentrations and arterial stiffness in men with type 2 diabetes mellitus.
Fukui M; Ose H; Kitagawa Y; Yamazaki M; Hasegawa G; Yoshikawa T; Nakamura N
Metabolism; 2007 Sep; 56(9):1167-73. PubMed ID: 17697857
[TBL] [Abstract][Full Text] [Related]
9. Elevated high sensitivity C-reactive protein levels in aging men with low testosterone.
Kaplan SA; Johnson-Levonas AO; Lin J; Shah AK; Meehan AG
Aging Male; 2010 Jun; 13(2):108-12. PubMed ID: 20001470
[TBL] [Abstract][Full Text] [Related]
10. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.
Abrahamian H; Endler G; Exner M; Mauler H; Raith M; Endler L; Rumpold H; Gerdov M; Mannhalter C; Prager R; Irsigler K; Wagner OF
Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):38-41. PubMed ID: 17286233
[TBL] [Abstract][Full Text] [Related]
11. [High-sensitive C-reactive protein and Type 2 diabetic nephropathy].
Liao L; Lei MX; Chen HL; Wu J; Guo LJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):627-30. PubMed ID: 16114543
[TBL] [Abstract][Full Text] [Related]
12. Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus.
Hernandez TL; Capell WH; Wolfe P; Gerard LA; Eckel RH
Am J Cardiol; 2006 Dec; 98(12):1656-9. PubMed ID: 17145229
[TBL] [Abstract][Full Text] [Related]
13. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial.
Azadbakht L; Atabak S; Esmaillzadeh A
Diabetes Care; 2008 Apr; 31(4):648-54. PubMed ID: 18184902
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.
Mojahedi MJ; Bonakdaran S; Hami M; Sheikhian MR; Shakeri MT; Aiatollahi H
Iran J Kidney Dis; 2009 Jan; 3(1):12-6. PubMed ID: 19377253
[TBL] [Abstract][Full Text] [Related]
15. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome.
Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S; Mohanty P
Curr Mol Med; 2008 Dec; 8(8):816-28. PubMed ID: 19075678
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
Hanefeld M; Marx N; Pfützner A; Baurecht W; Lübben G; Karagiannis E; Stier U; Forst T
J Am Coll Cardiol; 2007 Jan; 49(3):290-7. PubMed ID: 17239709
[TBL] [Abstract][Full Text] [Related]
17. Relationship between residual renal function, inflammation, and anemia in peritoneal dialysis.
Pérez-Flores I; Coronel F; Cigarrán S; Herrero JA; Calvo N
Adv Perit Dial; 2007; 23():140-3. PubMed ID: 17886621
[TBL] [Abstract][Full Text] [Related]
18. Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction.
Makhlouf AA; Mohamed MA; Seftel AD; Niederberger C
Int J Impot Res; 2008; 20(2):157-61. PubMed ID: 17703222
[TBL] [Abstract][Full Text] [Related]
19. [Testosterone-binding capacity, free-plasma testosterone fraction, and free-plasma testosterone concentration in andrological patients (author's transl)].
Geisthövel W; von zur Mühlen A
Dtsch Med Wochenschr; 1976 Jan; 101(2):37-42. PubMed ID: 1245153
[TBL] [Abstract][Full Text] [Related]
20. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic.
Corona G; Mannucci E; Petrone L; Ricca V; Balercia G; Mansani R; Chiarini V; Giommi R; Forti G; Maggi M
Int J Impot Res; 2006; 18(2):190-7. PubMed ID: 16136189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
